Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

111, Inc. (YI) Cash Flow Statement

111, Inc. (YI) generated $119.1M of operating cash flow over the twelve months to 2026-06-30, spent $4.5M on capital expenditure and had free cash flow of $114.7M, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

Pharmaceutical Retailers · Healthcare
—
Price chart with a free account
Market cap
25.1M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
15 Dec, in 52 days
LineFY2018
Dec 18
FY2019
Dec 19
FY2020
Dec 20
FY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Operating cash flow-0.34-0.51-0.12-0.69-0.02-0.450.260.120.12
Capital expenditure0.010.020.030.060.030.010.020.00-0.00
Free cash flow-0.36-0.53-0.14-0.75-0.05-0.460.250.110.11
Share repurchases—0.020.010.01—————
Stock-based compensation0.050.050.080.150.160.230.020.01—

USD billions · SEC XBRL

111, Inc. — questions

What is 111, Inc.'s operating cash flow?
$119.1M over the twelve months to 2026-06-30.
How much does 111, Inc. spend on capital expenditure?
$4.5M over the twelve months to 2026-06-30.
What is 111, Inc.'s free cash flow?
$114.7M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.

Every figure on this page comes from 111, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.